share_log

康龍化成:董事會會議通告

PHARMARON: NOTICE OF BOARD MEETING

HKEX ·  Mar 12 17:00

Summary by Moomoo AI

康龍化成(北京)新藥技術股份有限公司宣佈,將於2025年3月26日(星期三)召開董事會會議,主要議程包括審議及批准2024年度業績報告,同時將考慮建議派發末期股息事項。會議將由董事會主席樓柏良博士主持,出席會議的董事會成員包括執行董事、非執行董事及獨立非執行董事。
康龍化成(北京)新藥技術股份有限公司宣佈,將於2025年3月26日(星期三)召開董事會會議,主要議程包括審議及批准2024年度業績報告,同時將考慮建議派發末期股息事項。會議將由董事會主席樓柏良博士主持,出席會議的董事會成員包括執行董事、非執行董事及獨立非執行董事。
PHARMARON (Peking) New Drug Technology Co., Ltd. announced that a Board of Directors meeting will be held on March 26, 2025 (Wednesday), with the main agenda including the review and approval of the 2024 annual performance report, and to consider the proposal for the distribution of the final dividend. The meeting will be chaired by Dr. Lou Bai-Liang, Chairman of the Board, with attending board members including executive directors, non-executive directors, and independent non-executive directors.
PHARMARON (Peking) New Drug Technology Co., Ltd. announced that a Board of Directors meeting will be held on March 26, 2025 (Wednesday), with the main agenda including the review and approval of the 2024 annual performance report, and to consider the proposal for the distribution of the final dividend. The meeting will be chaired by Dr. Lou Bai-Liang, Chairman of the Board, with attending board members including executive directors, non-executive directors, and independent non-executive directors.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

    Statement

    This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.